Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Originally reported by New York Times
Related Articles
Oil nears highest price since start of Iran war
Oil nears highest price since start of Iran war12 minutes agoShareSaveAdd as preferred on GoogleFaarea MasudandNick Edse...
US federal student loan borrowers: Have you had your loan forgiven? We’d like to hear from you
Some federal students have been told if they are eligible for automatic student loan forgiveness. Photograph: Joseph Cr...
Nike is set to report earnings after the bell. Here's what Wall Street expects
Nike is expected to report a steep decline in quarterly profit and flat sales on Tuesday as the sneaker giant continues ...
Centuries-old pottery firm Denby set to call in administrators
Almost 600 jobs could go amid higher cost of gas and labour and softening consumer demand Denby is set to call in admini...